We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

131 hedge funds and large institutions have $358M invested in Precision BioSciences in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 42 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more call options, than puts

Call options by funds: $2.6M | Put options by funds: $1.53M

24% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 17

14% more capital invested

Capital invested by funds: $313M → $358M (+$44.5M)

2% more funds holding

Funds holding: 128 → 131 (+3)

7% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 42

3.13% less ownership

Funds ownership: 53.11% → 49.98% (-3.1%)

Holders
131
Holders Change
+3
Holders Change %
+2.34%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
45
Reduced
42
Closed
17
Calls
$2.6M
Puts
$1.53M
Net Calls
+$1.07M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
CS
Candriam SCA
Luxembourg
+$6.34M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$4.8M
3
JP Morgan Chase
JP Morgan Chase
New York
+$3.13M
4
Morgan Stanley
Morgan Stanley
New York
+$2.18M
5
Capital World Investors
Capital World Investors
California
+$2.07M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$23.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.38M
3
UBS Group
UBS Group
Switzerland
-$3.13M
4
BlackRock
BlackRock
New York
-$2.97M
5
GTC
Ghost Tree Capital
New York
-$2.07M

DTIL Hedge Fund Activity: Q2 2021 in Review

131 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2021, worth a combined $358M — up 14% from $313M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DTIL positions and 17 closed out — a net gain of 4 holders — while 45 added to existing stakes and 42 trimmed.

The largest buyer was Candriam SCA, opening a new position worth an estimated $6.34M. The largest seller was State Street, cutting an estimated $23.7M.

  • 131 institutional investors held Precision BioSciences (DTIL) as of Q2 2021, up from 128 in Q1 2021.
  • Funds reported $358M of Precision BioSciences stock for Q2 2021, up 14% quarter-over-quarter.
  • 21 funds opened new Precision BioSciences positions in Q2 2021 and 17 closed out, a net change of +4 holders.
  • The largest Precision BioSciences buyer in Q2 2021 was Candriam SCA, an estimated $6.34M added.
  • The largest Precision BioSciences seller in Q2 2021 was State Street, an estimated $23.7M sold.

Based on aggregated 13F filings for Q2 2021.